Stimuli‐responsive nanoparticles have the potential to improve the delivery of therapeutics to a specific cell or region within the body. There are many stimuli that have shown potential for specific release of cargo, including variation of pH, redox potential, or the presence of enzymes. pH variation has generated significant interest for the synthesis of stimuli‐responsive nanoparticles because nanoparticles are internalized into cells via vesicles that are acidified. Additionally, the tumor microenvironment is known to have a lower pH than the surrounding tissue. In this review, different strategies to design pH‐responsive nanoparticles are discussed, focusing on the use of charge‐shifting polymers, acid labile linkages, and crosslinking.
First reported less than a decade ago, the α,βunsaturated acyl azolium has emerged as a central reactive intermediate for reaction discovery using N-heterocyclic carbene catalysis. In this Perspective, an introduction to the four main reactivity patterns accessible from this intermediate is provided. The Perspective is handled in a largely chronological fashion, with an emphasis on alternate approaches to the key intermediate and first-in-class reaction cascades. Finally, a brief discussion of emerging trends in this field of catalysis is presented. Although not exhaustive, the Perspective provides an overview of this active area of research and serves as a guide for future investigations.
The catalytic umpolung of imines remains an underdeveloped approach to reaction discovery.H erein we report an enantioselective aza-Stetter reaction that proceeds via imine umpolung using N-heterocyclic carbene catalysis.T he reaction proceeds with high levels of enantioselectivity (all ! 96:4 er) and good generality (21 examples). Mechanistic studies are reported and are consistent with turnover-limiting addition of the NHC to the imine. Figure 1. Previously and this work.
Self-immolative polymers have significant potential for applications
such as drug or gene delivery. However, to realize this potential,
such materials need to be customized to respond to specific variations
in biological conditions. In this work, we investigated the design
of new star-shaped self-immolative poly(ethyl glyoxylate)s (PEtGs)
and their incorporation into responsive nanoparticles. PEtGs are a
subclass of stimulus-responsive self-immolative polymers, which can
be combined with different stimuli-responsive functionalities. Two
different tetrathiol initiators were used for the polymerization in
combination with a variety of potential pH-responsive end-caps, yielding
a library of star PEtG polymers which were responsive to pH. Characterization
of the depolymerization behavior of the polymers showed that the depolymerization
rate was controlled by the end caps rather than the architecture of
the polymer. A selection of the star polymers were modified with amines
to allow introduction of charge-shifting properties. It was shown
that pH-responsive nanoparticles could be prepared from these modified
polymers and they demonstrated pH-dependent particle disruption. The
pH responsiveness of these particles was studied by dynamic light
scattering and 1H nuclear magnetic resonance spectroscopy.
Herein we report the cycloisomerization of electron-poor 1,5-dienes via the β-azolium ylide to give enantioenriched cyclopentenes. The reaction is mediated by a chiral N-heterocyclic carbene (NHC) catalyst, exploits readily available substrates, has good generality (17 examples), and displays excellent enantioselectivity (mostly >94:6). Studies demonstrating the viability of a related dynamic kinetic resolution are reported, as are those with alternate tethers and derivatizations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.